Literature DB >> 29795434

Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.

Chun Kei Kris Ma1,2, Irene García-Cadenas3, María Laura Fox4, Sylvia Ai5, Ian Nivison-Smith5,6, Samuel Thomas Milliken5, Anthony Dodds5, Keith Fay5, David D F Ma5,7, Rodrigo Martino3, Jorge Sierra3, John Moore5,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29795434     DOI： 10.1038/s41409-018-0215-4

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.

Authors:  Armin Rashidi; Todd E DeFor; Shernan G Holtan; Bruce R Blazar; Daniel J Weisdorf; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-17       Impact factor: 5.742

2.  Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study.

Authors:  Shernan G Holtan; Jingbo Yu; Dilan Paranagama; Jackson Tang; Hannah K Choe; Ahmad Naim; H Joachim Deeg; John Galvin
Journal:  Bone Marrow Transplant       Date:  2022-06-23       Impact factor: 5.174

3.  Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.

Authors:  Shuang Fan; Wen-Xuan Huo; Yang Yang; Meng-Zhu Shen; Xiao-Dong Mo
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

Review 4.  Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease.

Authors:  Stephanie Kim; Pavan Reddy
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.